A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Epstein-Barr Virus Antibody Panel
Test Code6421
Alias/See Also
LAB863
EBV ANTIBODY BANEL
VIRAL CAPSID ANTIBODY
EBV VCA PANEL
EBV ANTIBODY BANEL
VIRAL CAPSID ANTIBODY
EBV VCA PANEL
CPT Codes
86664, 86665 (x2)
Includes
Epstein-Barr Virus VCA Antibody (IgM), Epstein-Barr Virus VCA Antibody (IgG), Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
Preferred Specimen
1 mL serum
Minimum Volume
0.8 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Methodology
Immunoassay (IA)
Setup Schedule
Tues-sat
Report Available
2-5 days
Reference Range
Epstein-Barr Virus VCA Antibody (IgM)
Epstein-Barr Virus VCA Antibody (IgG)
Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
U/mL | Interpretation |
<36.00 | Negative |
36.00-43.99 | Equivocal |
>43.99 | Positive |
Epstein-Barr Virus VCA Antibody (IgG)
U/mL | Interpretation |
<18.00 | Negative |
18.00-21.99 | Equivocal |
>21.99 | Positive |
Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
U/mL | Interpretation |
<18.00 | Negative |
18.00-21.99 | Equivocal |
>21.99 | Positive |
Clinical Significance
Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA-IgG is typically detectable at clinical presentation, and persists for life. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |